THTX

Theratechnologies Inc. (THTX) is a Montreal-based biopharmaceutical company dedicated to developing and commercializing innovative therapies tailored to address significant unmet medical needs, particularly in the fields of HIV, oncology, and metabolic disorders. With a strategic focus on specialized drug delivery systems and targeted therapies, Theratechnologies aims to improve patient outcomes across North America and Europe. Boasting a robust pipeline of clinical and preclinical candidates, the company is well-positioned to leverage its expertise in biopharmaceutical development to enhance its market presence and drive sustainable growth.